scholarly journals Research and development of 2-ethyl-6-methyl-3-oxypyridine succinate nano-form for the treatment of epilepsy

2019 ◽  
Vol 10 (4) ◽  
pp. 26-38
Author(s):  
G. G. Avakyan ◽  
T. A. Voronina ◽  
L. N. Nerobkova ◽  
G. N. Avakyan

The aimis to develop an antiepileptic drug based on polymer nanoparticles with 2-ethyl-6-methyl-3-oxypyridine succinate to facilitate the drug transport through the blood-brain barrier.Materials and methods.The nano-drug was created using the biologically active substance 2-ethyl-6-methyl-3-hydroxypyridine succinate and polybutyl cyanoacrylate (PBCA) nanoparticles. The advantages of this nano-form over the active ingredient of the same drug were studied using experimental models: the maximum electroshock test (MES), the antagonism test with corazol, models with a cobaltinduced epileptic focus and secondary generalized convulsions, and models of status epilepticus.Results.The antiseizure effects of the nanoform on the experimental models of epilepsy are identified.Conclusion.The nano-drug reduces the number of secondary generalized clonic-tonic seizures by 7.8 times; it also reduces 10-fold the animal mortality and diminishes the seizure manifestations that occur in the interictal period of the epileptic status.

2020 ◽  
Author(s):  
Giorgia Conte ◽  
Alberto Parras ◽  
Mariana Alves ◽  
Ivana Ollà ◽  
Laura de Diego-Garcia ◽  
...  

AbstractObjectivePharmacoresistance and the lack of disease-modifying actions of current anti-seizure drugs persist as major challenges in the treatment of epilepsy. Experimental models of chemoconvulsant-induced status epilepticus remain the models of choice to discover potential anti-epileptogenic drugs but doubts remain as to the extent to which they model human pathophysiology. The aim of the present study was to compare the molecular landscape of the intraamygdala kainic acid model of status epilepticus in mice with findings in resected brain tissue from patients with drug-resistant temporal lobe epilepsy (TLE).MethodsStatus epilepticus was induced via intraamygdala microinjection of kainic acid in C57BL/6 mice and gene expression analysed via microarrays in hippocampal tissue at acute and chronic time-points. Results were compared to reference datasets in the intraperitoneal pilocarpine and intrahippocampal kainic acid model and to human resected brain tissue (hippocampus and cortex) from patients with drug-resistant TLE.ResultsIntraamygdala kainic acid injection in mice triggered extensive dysregulation of gene expression which was ∼3-fold greater shortly after status epilepticus (2729 genes) when compared to epilepsy (412). Comparison to samples of patients with TLE revealed a particular high correlation of gene dysregulation during established epilepsy. Pathway analysis found suppression of calcium signalling to be highly conserved across different models of epilepsy and patients. CREB was predicted as one of the main up-stream transcription factors regulating gene expression during acute and chronic phases and inhibition of CREB reduced seizure severity in the intraamygdala kainic acid model.SignificanceOur findings suggest the intraamygdala kainic acid model faithfully replicates key molecular features of human drug-resistant temporal lobe epilepsy and provides potential rationale target approaches for disease-modification through new insights into the unique and shared gene expression landscape in experimental epilepsy.Key point boxMore genes show expression changes shortly following intraamygdala kainic acid-induced status epilepticus when compared to established epilepsy.The intraamygdala kainic acid mouse model mimics closely the gene expression landscape in the brain of patients with temporal lobe epilepsy.Supressed calcium signalling in the brain as common feature across experimental models of epilepsy and patients with temporal lobe epilepsy.CREB is a major up-stream transcription factor during early changes following status epilepticus and once epilepsy is established.


2013 ◽  
Vol 2013 ◽  
pp. 1-19 ◽  
Author(s):  
Keite Lira de Almeida França ◽  
Antônio-Carlos Guimarães de Almeida ◽  
Antonio Fernando Catelli Infantosi ◽  
Mario Antônio Duarte ◽  
Gilcélio Amaral da Silveira ◽  
...  

Structural rearrangement of the dentate gyrus has been described as the underlying cause of many types of epilepsies, particularly temporal lobe epilepsy. It is said to occur when aberrant connections are established in the damaged hippocampus, as described in human epilepsy and experimental models. Computer modelling of the dentate gyrus circuitry and the corresponding structural changes has been used to understand how abnormal mossy fibre sprouting can subserve seizure generation observed in experimental models when epileptogenesis is induced by status epilepticus. The model follows the McCulloch-Pitts formalism including the representation of the nonsynaptic mechanisms. The neuronal network comprised granule cells, mossy cells, and interneurons. The compensation theory and the Hebbian and anti-Hebbian rules were used to describe the structural rearrangement including the effects of the nonsynaptic mechanisms on the neuronal activity. The simulations were based on neuroanatomic data and on the connectivity pattern between the cells represented. The results suggest that there is a joint action of the compensation theory and Hebbian rules during the inflammatory process that accompanies the status epilepticus. The structural rearrangement simulated for the dentate gyrus circuitry promotes speculation about the formation of the abnormal mossy fiber sprouting and its role in epileptic seizures.


Author(s):  
Marco de Curtis ◽  
Andrea O. Rossetti ◽  
Diogo Vila Verde ◽  
Erwin A. van Vliet ◽  
Christine T. Ekdahl

2017 ◽  
Vol 75 ◽  
pp. 56-59 ◽  
Author(s):  
Muhammad Usama Ashhar ◽  
Mohd. Zubair Ahmad ◽  
Vikas Jain ◽  
Nidhi B. Agarwal ◽  
Farhan J. Ahmad ◽  
...  

2012 ◽  
Vol 64 (3) ◽  
pp. 1207-1216 ◽  
Author(s):  
D. Hrncic ◽  
Aleksandra Rasic-Markovic ◽  
Jelica Bjekic-Macut ◽  
Veselinka Susic ◽  
D. Mladenovic ◽  
...  

Epilepsy is one of the leading neurological disorders and affects 1-2% of the world?s population. Generally, it is a result of an imbalance between excitatory and inhibitory phenomena in the central nervous system (CNS), but the mechanisms of its initiation and propagation still require further investigations. Experimental models represent one of the most powerful tools to better understand the mechanisms of epileptogenesis. Nitric oxide (NO) is gaseous molecule with pleiotropic physiological and pathological effects in almost all organ systems and intriguing biological relevance, especially in the CNS where it acts as a gaseous neurotransmitter. The role of NO in the generation of epilepsy is highly contradictory, since there is evidence of its anticonvulsive, as well as proconvulsive properties. Therefore, we will discuss in this review the involvement of NO-mediated signaling pathways in the mechanisms of epileptogenesis, taking into account the findings revealed in experimental studies on animal models of epilepsy.


2021 ◽  
Author(s):  
◽  
Nurul Akmar Binti Che Zaudin

<p>Efficient and effective delivery of fertilisers, herbicides, pesticides and growth regulating compounds to plants is the subject of much ongoing research. The objective of this research was to develop nano-formulations for delivery of compounds to plants. Two formulations were developed: the first was solution-based focused on encapsulation of the active ingredient in a nanoemulsion. Nanoemulsions should be ideal for facilitating transfer of compounds to plant leaves as their size correlates well with the nanoscale surface features of leaves, achieving significantly greater total contact area between the oil droplets and the leaves. The second nano-formulation was solid-state based, focused on locating the active ingredient within the tubules of a nanotube clay. For proof-of-concept two synthetic plant hormones, N-phenyl-N‘-(2-chloro-4-pyridyl)urea (CPPU) or forchlorfenuron, a synthetic cytokinin, and 2,4-dichlorophenoxyacetic acid (2,4-D), a synthetic auxin, were chosen for encapsulation. CPPU is a phenylurea derivative that shows strikingly strong cytokinin-like activity in plants, including delaying senescence. It is highly water insoluble, but soluble in organic solvents. It is widely used in a variety of crops, particularly kiwifruit and table grapes. Delivery of CPPU safely, efficiently and at the appropriate dosage is a priority as overdosing or incorrect timing of application causes detrimental effects on fruit firmness and other quality attributes. Auxins are also a group of plant hormone. 2,4-D is a synthetic auxin which has been widely used at high concentrations as a herbicide, at medium concentrations for fruit thinning, and at low concentrations promotes root initiation, but at even lower concentrations promote root elongation. Consequently, careful control of dosage is required to obtain the desired effect. The nanoemulsion system developed was water/polysorbate 80/glycerol/soybean oil. The active ingredient, CPPU, was incorporated into the nanoemulsion via the oil phase in a pre-concentrate which was then crash diluted to yield the final nanoemulsion. Nanoemulsions are created only when the concentrate is located in the bicontinuous or oil-in-water microemulsion regions of the phase diagram. The droplet size of the nanoemulsions was measured using dynamic light scattering with droplets ranging in size from 30 – 100 nm. The CPPU-loaded nanoemulsions were stable for more than three days. To determine if the nanoemulsion was an effective delivery system, a leaf senescence bioassay was conducted to test the senescence-delaying effect of the CPPU-loaded nanoemulsions when applied to explants. The nanoemulsions were applied directly to the leaves of dwarf bean explants. Chlorophyll was extracted from the leaves and measured spectrophotometrically before and several days following treatment. The CPPU-loaded nanoemulsions enhanced the effectiveness of CPPU in delaying leaf senescence compared with the control experiments, including direct application of CPPU. A >10-fold reduction in CPPU concentration was achieved. The second delivery method was a solid-state preparation, using halloysite clay nanotubes loaded with 2,4-D. A rooting bioassay using mung bean explants was used for proof of concept. Application of 2,4-D nanotubes to the cut end of a young stem, without roots, stimulated root formation compared to controls after 10 days and at a lower applied concentration. The retardation of root elongation, relative to controls after 13 days, potentially indicated continued slow release of the active ingredient from the nanotubes. Results obtained from this research indicate that nano-formulations have the potential to deliver biologically active compounds to plants in the horticultural and agricultural sectors at effective concentrations lower than in current usage.</p>


Author(s):  
Lidya Tumewu ◽  
Irfan Rayi Pamungkas ◽  
Hilkatul Ilmi ◽  
Achmad Fuad Hafid ◽  
Indah Setyawati Tantular ◽  
...  

Background: Andrographis paniculata is a herbaceous plant in the Acanthaceae family, that is widely used as a traditional medicine in Asian countries and known to exhibit a wide range of pharmacological effects. Recent studies have provided an overview of the great potential of A. paniculata as an analgesic. The ethanol extract and ethyl acetate (EA) fraction of A.paniculata were shown to contain diterpene lactone compounds, which may be useful as a potential active ingredient in analgesic drugs. The development of a herbal medicine based drug requires an effective and high quality active ingredient. Therefore, this research was aimed to compare the analgesic activity of ethanol extract and EA fraction based on their andrographolide content and further to determine the more viable active substance for analgesic herbal medicine based drug development. Method: The andrographolide content in the ethanol extract and EA fraction was determined by High Pressure Liquid Chromatography (HPLC). Measurement of analgesic activity was performed by writhing test. The experimental animals were randomly divided into eight groups consisting of 5 mice in each. Group 1 (negative control) received 1% Tween-80 in normal saline. Group 2 (positive control) received a standard analgesic drug (diclofenac sodium) at a dose of 40 mg/kg body weight. Group 3, 4, and 5 received ethanol extract while Group 6, 7, and 8 received EA fraction, each at a dose of 12.5, 25, and 50 mg andrographolide/kg body weight, respectively. Each mouse was injected intraperitoneally with 1% acetic acid at a dose of 10 ml/kg body weight 30 minutes after oral administration of the treatments. The number of writhes were counted 5 min after acetic acid injection over a period of 45 min. Results: Andrographolide content in ethanol extract and EA fraction was 15.66±0.28 and 21.25±1.08 % w/w, respectively. Ethanol extract and EA fraction displayed analgesic activity of 67.68% and 70.91% respectively, at a dose of 50 mg andrographolide/kg body weight. The positive control at a dose of 40 mg/kg body weight showed an analgesic activity of 74.33%. Statistical analysis showed no significant differences between EA fraction at a dose of 50 mg andrographolide/kg body weight and ethanol extract at the same dose as well as the positive control (P> 0.05). The effective dose 50% (ED50) of the ethanol extract and EA fraction was determined to be 29.49 and 25.55 mg/kg body weight, respectively. Conclusion: It was possible to use andrographolide content as an indicator for the analgesic activity of A.paniculata. Ethanol extract and EA fraction of A. paniculata at the same dose of andrographolide showed similar analgesic activity. The amount of ethanol extract which needed to reach similar analgesic activity was higher than EA fraction. Therefore, EA fraction likely has greater potential as an analgesic active substance due to its higher content of andrographolide; however further study is needed to develop it as a dosage form.


Sign in / Sign up

Export Citation Format

Share Document